Isolation and structural identification of an impurity in fluconazole bulk drug substance
Authors:
- Vaijanath G. DongreVDVaijanath G. Dongre
- Pradeep D. GhugarePGPradeep D. Ghugare
- Pravin P. KarmusePKPravin P. Karmuse
- Satish R. SoudagarSSSatish R. Soudagar
- Nalinakshya PandaNPNalinakshya Panda
- Ashok KumarAKAshok Kumar
- 1 November 2007
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 45 (3) , 422-429
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Preparative isolation and structural elucidation of impurities in fluconazole by LC/MS/MSJournal of Pharmaceutical and Biomedical Analysis, 2006
- Liquid chromatography–tandem mass spectrometric method for the analysis of fluconazole and evaluation of the impact of phenolic compounds on the concentration of fluconazole in Candida albicansJournal of Pharmaceutical and Biomedical Analysis, 2004
- Liquid/liquid extraction using 96-well plate format in conjunction with hydrophilic interaction liquid chromatography–tandem mass spectrometry method for the analysis of fluconazole in human plasmaJournal of Pharmaceutical and Biomedical Analysis, 2003
- Particle beam-mass spectrometric analysis of difluorophenyl triazole compounds using normal phase-HPLCTalanta, 1997
- Spectral characterization of fluconazoleJournal of Pharmaceutical and Biomedical Analysis, 1996
- Conversion of 4‐amino‐4H‐1,2,4‐triazole to 1,3‐bis(1H‐azol‐l‐yl)‐2‐aryl‐2‐propanols and 1‐phenacyl‐4‐[(benzoyl or 4‐toluenesulfonyl)‐imino]‐(1H‐1,2,4‐triazolium) YlidesJournal of Heterocyclic Chemistry, 1993
- Fluconazole: A New Triazole Antifungal AgentThe American Journal of the Medical Sciences, 1991
- FluconazoleDrugs, 1990